# Novartis Gene Therapies, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/novartis-gene-therapies-inc/04406f28-2c1b-4c68-ab75-a9862bfc9169

> Inspection records and compliance data for Novartis Gene Therapies, Inc. in San Diego, California. Access full analysis and detailed observations.

---

## Details

- Name: Novartis Gene Therapies, Inc.
- FEI Number: 3014617030
- City: San Diego
- State: California
- Country Name: United States
- Address Line 1: 10210 Campus Point Dr Ste 300
- Zip Code: 92121
- Facility Type: Control Testing Lab

## Related Documents

- [FDA Inspection 1155029 - Novartis Gene Therapies, Inc. - 2021-08-27](https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/5fc85103-2cc5-4449-a02e-e29d0a3c1dd0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2021
- [483 - Novartis Gene Therapies, Inc. - 2021-08-23](https://www.keypedia.com/records/483/novartis-gene-therapies-inc/4a16f348-bb9d-4649-b406-4d27d51110e4) — source: FDA, date: August 23, 2021
- [483 - Novartis Gene Therapies, Inc. - 2019-08-02](https://www.keypedia.com/records/483/novartis-gene-therapies-inc/85c00fe0-e2f3-427e-80bc-ff47ccffb85a) — source: FDA, date: August 2, 2019
- [OTHER_CORRESPONDENCE - Novartis Gene Therapies, Inc. - 2019-08-02](https://www.keypedia.com/records/other_correspondence/novartis-gene-therapies-inc/e848efbe-98af-4b81-a414-7d8ed0d1aa0e) — source: FDA, date: August 2, 2019
- [483 - Novartis Gene Therapies, Inc. - 2019-08-02](https://www.keypedia.com/records/483/novartis-gene-therapies-inc/91f9bee6-7ad5-4836-8f07-46468e2a2510) — source: FDA, date: August 2, 2019
- [FDA Inspection 1098391 - Novartis Gene Therapies, Inc. - 2019-08-02](https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/b248dcf9-f018-40c9-81cf-1316bcb9a3bf) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2019
- [EIR - Novartis Gene Therapies, Inc. - 2019-02-15](https://www.keypedia.com/records/eir/novartis-gene-therapies-inc/f5f81226-4da7-4cdc-91da-5e61e1786be0) — source: FDA, date: February 15, 2019

## Related Companies

- [Quotient Sciences - Philadelphia, LLC](https://www.keypedia.com/companies/quotient-sciences-philadelphia-llc/89a4fd48-2064-499b-a555-ac6f8c924b41)
- [WuXi ATU Co., Ltd.](https://www.keypedia.com/companies/wuxi-atu-co-ltd/12f097ce-5a4f-4b66-9bf7-bc54aa280837)
- [TERUMO YAMAGUCHI CORPORATION](https://www.keypedia.com/companies/terumo-yamaguchi-corporation/475daebd-e907-4c43-855d-63dd50cf5a9f)
- [Eisai Company Ltd.](https://www.keypedia.com/companies/eisai-company-ltd/3b8d9042-088d-4b84-9382-fcdcfd5ef360)
- [Ajinomoto Althea, Inc.](https://www.keypedia.com/companies/ajinomoto-althea-inc/75fb5ea8-b86f-45c1-946e-80c73765f544)
- [Biogen U.S. Corporation](https://www.keypedia.com/companies/biogen-us-corporation/515ce53c-77be-414c-bcf4-c66be60b098e)
- [Smith & Nephew Wound Management](https://www.keypedia.com/companies/smith-nephew-wound-management/93a0c13a-73e3-4058-b819-d208e5fbdb5a)
- [United Therapeutic Corporation](https://www.keypedia.com/companies/united-therapeutic-corporation/fda8d6ce-d684-4496-89b6-5f8b526d83f7)
- [Cardinal Health 414, LLC](https://www.keypedia.com/companies/cardinal-health-414-llc/b1d6d59b-695c-42a4-8272-d3e5a96de306)
- [Astellas Pharma Inc.](https://www.keypedia.com/companies/astellas-pharma-inc/b0bdaca5-537e-4e43-9609-7ae4702f2f86)

## Related Officers

- [Rebecca Clancy](https://www.keypedia.com/people/rebecca-clancy/3d75c3b8-a121-4dc7-8ee7-cc6721949f95)
- [Regulatory Affairs Specialist](https://www.keypedia.com/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)